NCT00429520已完成4 期
Prospective, Multicentre, Not Controlled Clinical Study to Investigate Efficacy and Tolerability of the Hyaluronic Acid Filler IMD1 Basic After Single Bilateral Injection for Correction of Nasolabial Folds (NLF)
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 114
- 试验地点
- 2
- 主要终点
- Severity rating scale assessed by independent rater
研究概览
简要总结
Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •main inclusion criteria: severity rating scale grade 3 or 4
排除标准
- •main exclusion criterion: other nasolabial fold corrections within 6 months prior to study entry
结局指标
主要结局
Severity rating scale assessed by independent rater
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Princess® VOLUME Lidocaine for the Correction of Nasolabial FoldsNasolabial Fold, HypoplasticNCT03050710Croma-Pharma GmbH62
已完成
不适用
Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial FoldsCorrection of Nasolabial FoldsNCT03611491Croma-Pharma GmbH60
已完成
不适用
Multicenter Study to Evaluate the Safety and Efficacy of Revanesse® Ultra RetreatmentNasolabial Fold CorrectionNCT02984878Prollenium Medical Technologies Inc.71
已完成
1 期
Split-face Comparison Study to Assess ELAPR Compared to Juvéderm® for the Treatment of Nasolabial FoldsAgingNCT01463657Elastagen Pty Ltd30
已完成
1 期
Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy VolunteersCOVID-19NCT05696067Tatyana Zubkova200